Fujisawa M - Search Results

1

Shigemura K, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. J Urol. 2021 Apr;205(4):997-998. doi: 10.1097/JU.0000000000001513.02. Epub 2021 Feb 3. J Urol. 2021. PMID: 33533647 No abstract available.

2

Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan.

Shigemura K, Tanaka K, Okada H, Nakano Y, Kinoshita S, Gotoh A, Arakawa S, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Jpn J Infect Dis. 2005 Oct;58(5):303-8. Jpn J Infect Dis. 2005. PMID: 16249626

3

Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy.

Shigemura K, Tanaka K, Yasuda M, Ishihara S, Muratani T, Deguchi T, Matsumoto T, Kamidono S, Nakano Y, Arakawa S, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. World J Urol. 2005 Nov;23(5):356-60. doi: 10.1007/s00345-005-0024-4. Epub 2005 Oct 28. World J Urol. 2005. PMID: 16254727 Clinical Trial.

4

Presence of a mutation in ponA1 of Neisseria gonorrhoeae in numerous clinical samples resistant to various beta-lactams and other, structurally unrelated, antimicrobials.

Shigemura K, Shirakawa T, Massi N, Tanaka K, Arakawa S, Gotoh A, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. J Infect Chemother. 2005 Oct;11(5):226-30. doi: 10.1007/s10156-005-0403-1. J Infect Chemother. 2005. PMID: 16258817

5

Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.

Shigemura K, Shirakawa T, Wada Y, Kamidono S, Fujisawa M, Gotoh A. Shigemura K, et al. Among authors: fujisawa m. Urology. 2005 Dec;66(6):1239-44. doi: 10.1016/j.urology.2005.06.076. Urology. 2005. PMID: 16360450

6

Rapid detection of the fluoroquinolone resistance-associated ParC mutation in Neisseria gonorrhoeae using TaqMan probes.

Shigemura K, Shirakawa T, Tanaka K, Arakawa S, Gotoh A, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Int J Urol. 2006 Mar;13(3):277-81. doi: 10.1111/j.1442-2042.2006.01264.x. Int J Urol. 2006. PMID: 16643623

7

Larger prostate causes higher frequency of infectious complications in prostate biopsy.

Shigemura K, Arakawa S, Nakano Y, Hara I, Tanaka K, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Urol Int. 2006;76(4):321-6. doi: 10.1159/000092055. Urol Int. 2006. PMID: 16679833

8

Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).

Shigemura K, Arakawa S, Sakai Y, Kinoshita S, Tanaka K, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Int J Urol. 2006 May;13(5):538-42. doi: 10.1111/j.1442-2042.2006.01359.x. Int J Urol. 2006. PMID: 16771722

9

Effect of sildenafil on arterial stiffness, as assessed by pulse wave velocity, in patients with erectile dysfunction.

Shigemura K, Arakawa S, Kamidono S, Nakano Y, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Int J Urol. 2006 Jul;13(7):956-9. doi: 10.1111/j.1442-2042.2006.01447.x. Int J Urol. 2006. PMID: 16882062

10

Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor.

Shigemura K, Tanaka K, Hara I, Muramaki M, Arakawa S, Fujisawa M. Shigemura K, et al. Among authors: fujisawa m. Hinyokika Kiyo. 2006 Jul;52(7):531-6. Hinyokika Kiyo. 2006. PMID: 16910585 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,506 results

Search Page